Vocab 5,6,7

Quiz 2 (n=90 words)

CHAPTER 5 (n=31)

pathogen: An organism, typically a microorganism, that can cause disease in a host.

pathogenicity: The ability of a pathogen to cause disease, which is influenced by factors such as its virulence, the mode of transmission, and the host's immune response.

virulence: The degree of pathogenicity of a pathogen, typically measured by its ability to invade host tissues and produce harmful effects, including toxins or inflammatory responses.

infectivity: The ability of a pathogen to establish an infection in a host, which is determined by factors such as the number of pathogens required to cause infection, their route of entry, and the host's susceptibility.

toxigenicity: The ability of a pathogen to produce toxins that can damage host tissues and contribute to disease severity, often impacting the host's immune response and overall health.

antigenicity: The ability of a pathogen to provoke an immune response, primarily through the recognition of specific molecules (antigens) by the host's immune system, ultimately leading to the production of antibodies.

antigenic variability: The ability of a pathogen to alter its surface antigens to evade detection and neutralization by the host's immune system, thereby enhancing its survival and persistence within the host.

coinfection: The presence of two or more pathogens in a single host at the same time, which can complicate the infection process and may result in increased disease severity, as the interactions between the pathogens can modulate immune responses and treatment outcomes.

superinfection: the subsequent infection of a host already infected by a different pathogen, which can occur when the immune system is compromised or altered due to the first infection, leading to more complex clinical challenges and treatment considerations.

endotoxin: A harmful substance produced by certain bacteria that, upon release into the host's bloodstream, can trigger severe immune responses, including fever, inflammation, and, in extreme cases, septic shock.

pyogenic: A term used to describe infections that produce pus, typically caused by certain types of bacteria, such as Staphylococcus aureus or Streptococcus species, which can lead to localized tissue destruction and systemic inflammatory responses.

endospores: A resistant structure formed by some bacteria, such as Bacillus and Clostridium species, that allows them to survive extreme environmental conditions, including heat, desiccation, and chemical exposure, making them a significant concern in infection control and sterilization processes.

exotoxins: Proteins secreted by certain bacteria that can cause damage to host cells and tissues, often leading to serious illnesses, such as diphtheria and tetanus, by disrupting cellular functions or triggering excessive immune responses.

viruses: Intracellular pathogens that can replicate only within living host cells, often leading to a wide range of diseases in humans and animals, including the common cold, influenza, and more serious conditions such as HIV and hepatitis.

virions: The complete viral particles that consist of a nucleic acid core, either DNA or RNA, surrounded by a protective protein coat (capsid), which can cause infections by attaching to and penetrating host cells.

latency: A period during which a virus remains dormant within a host cell, potentially evading the immune system and leading to reactivation and disease under certain conditions, such as stress or immunosuppression.

mycoses: Fungal infections that can affect various tissues in the body, often leading to symptoms ranging from mild to severe, depending on the immune status of the host and the specific type of fungus involved.

communicable: Diseases that can be transmitted from one host to another, either directly through contact or indirectly via vectors, droplets, or contaminated surfaces.

vector: An organism, often an insect, that carries and transmits pathogens to humans or other hosts, playing a critical role in the lifecycle of certain diseases.

prodrome: An early symptom or set of symptoms that precede the onset of a disease, often serving as a warning sign that may indicate the beginning of a communicable illness.

septicemia: A serious systemic infection that occurs when bacteria enter the bloodstream, leading to widespread inflammation and potentially resulting in organ failure if not treated promptly.

bacteremia: The presence of bacteria in the bloodstream, which can lead to similar symptoms as septicemia, often requiring immediate medical intervention to prevent severe complications.

septic shock: A life-threatening condition that arises when septicemia leads to dangerously low blood pressure and inadequate blood flow to organs, often requiring aggressive treatment to stabilize the patient.

purulent: A term used to describe a type of infection characterized by the production of pus, which often indicates the presence of bacteria and an inflammatory response in the body.

jaundice: A medical condition characterized by a yellowing of the skin and eyes, caused by an accumulation of bilirubin in the bloodstream, often associated with liver dysfunction or hemolytic disorders.

hemoptysis: The coughing up of blood or blood-stained mucus from the respiratory tract, which can be caused by various conditions including infections, tumors, or pulmonary embolism.

dysuria: A painful or difficult urination, often associated with urinary tract infections, bladder inflammation, or other urinary system disorders.

hematuria: The presence of blood in the urine, which may result from infections, kidney stones, or other underlying conditions affecting the urinary tract.

pyuria: The presence of pus in the urine, typically indicating a urinary tract infection or other inflammatory process affecting the urinary system.

Hyperemic: A condition characterized by an excess of blood in a particular area, often resulting in redness and inflammation, which may occur as a response to infection or injury in the urinary system.

CHAPTER 6 (n=31)

translocation: The process by which bacteria or other pathogens move from one part of the body, such as the gastrointestinal tract, into the bloodstream or other tissues, potentially leading to systemic infection and complications.

autosomes: Chromosomes that are not involved in determining the sex of an organism, typically in humans accounting for 22 pairs, with the 23rd pair being the sex chromosomes (XX or XY).

gametes: reproductive cells that unite during sexual reproduction to form a new organism, typically comprising sperm in males and ova in females, which contain half the number of chromosomes of a somatic cell.

transcription: The process by which the genetic information in DNA is transcribed to produce a complementary RNA strand, which can then be translated into proteins, playing a crucial role in gene expression and regulation.

genomics: The branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes, which encompasses the complete set of genetic material within an organism, allowing for a deeper understanding of hereditary information and the relationship between genetics and disease.

genotype: The genetic constitution of an individual organism, represented by the specific alleles inherited from both parents, which ultimately influences observable traits, or phenotypes.

phenotype: The physical and observable traits of an organism, which result from the interaction of the genotype with the environment, illustrating how genetics can manifest in various forms such as morphology, behavior, and physiology.

alleles: Different versions of a gene that are found at the same locus on homologous chromosomes, which can lead to variations in the traits expressed in an organism, thereby contributing to genetic diversity.

polygenic: A trait that is determined by multiple genes, rather than a single gene, resulting in a continuous range of phenotypic outcomes, such as height and skin color, highlighting the complex interplay of genetics in determining an organism's characteristics.

somatic mutation: A change in the DNA sequence of somatic cells, which are non-germline cells, that can lead to changes in phenotype but are not passed on to the next generation, demonstrating how environmental influences or errors during DNA replication can affect an organism's cellular function and development.

polymorphism: The occurrence of two or more distinct forms, or alleles, within a population at a given locus, which can lead to genetic variation among individuals and plays a crucial role in evolution and adaptation.

expressivity: The degree to which a genotype is expressed in an individual's phenotype, which can vary among individuals with the same genotype, demonstrating the influence of environmental factors and other modifiers on the phenotype.

penetrance: The proportion of individuals with a particular genotype who exhibit the associated phenotype, highlighting how certain factors can influence whether a phenotype manifests in those with the genotype.

single gene trait: A trait that is determined by a single gene, typically resulting in a clear-cut expression of the phenotype, contrasting with traits influenced by multiple genes or environmental factors.

homozygous: An individual having two identical alleles for a particular gene, which can lead to a consistent expression of the associated phenotype, as compared to heterozygous individuals who carry two different alleles.

heterozygous: An individual possessing two different alleles for a particular gene, which can lead to a variation in the expression of the phenotype compared to homozygous individuals.

sex-linked trait: A trait that is associated with a gene located on a sex chromosome, often resulting in different inheritance patterns between males and females, such as color blindness or hemophilia, which are more common in males due to their single X chromosome.

matrilineal: A term describing inheritance passed down through the maternal line, where lineage and ancestry are traced through mothers rather than fathers, influencing genetic traits and social structures.

hetroplasmy: The presence of more than one type of organellar DNA (mtDNA) within a cell or the tissues of an individual, which can affect mitochondrial function and lead to varying phenotypic traits.

karyotype: A karyotype is the number and appearance of chromosomes in the nucleus of a eukaryotic cell, used to diagnose genetic disorders and chromosomal abnormalities by analyzing the structure and number of chromosomes.

nondisjunction: The failure of homologous chromosomes or sister chromatids to separate properly during cell division, which can result in gametes with an abnormal number of chromosomes and may lead to conditions such as Down syndrome.

mosaicism: The presence of two or more genetically different cell lines within an individual, which can occur from processes such as mitotic errors or genetic mutations occurring during early development.

monosomy: A chromosomal condition characterized by the absence of one chromosome from the pair, leading to conditions such as Turner syndrome, where individuals have only one X chromosome instead of two.

trisomy: A chromosomal condition in which an individual has an extra copy of a chromosome, leading to conditions such as Trisomy 21, also known as Down syndrome, which is characterized by intellectual disability and distinct physical features.

genomic imprinting: A genetic phenomenon where certain genes are expressed in a parent-of-origin-specific manner, resulting in differential expression depending on whether the gene is inherited from the mother or the father, which can influence development and potential susceptibility to various diseases.

epigenetic: The study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence, which are influenced by environmental factors, lifestyle, and developmental stages, playing a critical role in processes such as cellular differentiation and the regulation of gene activity.

congenital: A term referring to conditions that are present from birth, which may result from genetic factors, environmental exposures, or a combination of both, often leading to a variety of health issues that may require early intervention.

organogenesis: the process by which the organs of a developing embryo form and mature, involving complex interactions between genetic and environmental influences, critical for proper fetal development and overall viability.

teratogen: any substance, organism, or physical agent that can cause malformation or abnormal development in a fetus during pregnancy, often leading to congenital abnormalities or developmental disorders, emphasizing the importance of understanding environmental impacts on prenatal health.

aneuploidy: the presence of an abnormal number of chromosomes in a cell, which can lead to various genetic disorders and developmental issues, often identified during prenatal screening and associated with conditions such as Down syndrome.

dyskinesia: a movement disorder characterized by involuntary and abnormal movements, which can be a consequence of neurological conditions or can emerge during fetal development due to factors like teratogenic exposure.

Hemolysis: the breakdown of red blood cells, which can lead to anemia and other complications during pregnancy, often associated with Rh incompatibility or certain infections that may impact fetal health.

CHAPTER 7 (n=28)

proliferation: the process by which cells divide and multiply, playing a crucial role in growth and development, as well as in the response to injury and disease.

differentiation: the process by which unspecialized cells develop into specialized cells, crucial for the formation of various tissues and organs in the body, and essential for maintaining homeostasis.

stem cells: undifferentiated cells that have the potential to develop into many different cell types, serving as a vital source for regeneration and repair in tissues throughout the body.

neoplasms: abnormal growths of tissue that result from excessive proliferation of cells, often leading to tumors that can be benign or malignant.

carcinogenesis: the process by which normal cells transform into cancerous cells, involving a series of genetic mutations and alterations that lead to uncontrolled cell growth and division.

oncogene: a gene that has the potential to cause cancer when mutated or expressed at high levels, playing a critical role in the regulation of cell growth and division.

tumor suppressor gene: a type of gene that helps prevent cancer by encoding proteins that regulate cell division, promote DNA repair, and induce apoptosis in cells with damaged DNA, thereby counteracting the effects of oncogenes.

protooncogene: a normal gene that can become an oncogene due to mutations or increased expression, functioning initially to promote cell growth and differentiation.

carcinogen: any substance, organism, or physical agent that is capable of causing cancer in living tissue, typically by inducing mutations or altering cellular processes.

autonomy: the ability of cells to regulate their own growth and division independently, which can contribute to tumor progression if control mechanisms are lost.

anaplasia: the loss of differentiation and the return to a more primitive or undifferentiated state in cancer cells, often characterized by increased malignancy and uncontrolled growth.

benign: a term used to describe tumors or growths that are not cancerous, do not invade surrounding tissues, and are typically not life-threatening.

malignant: tumors that are cancerous, capable of invading surrounding tissues, spreading to other parts of the body, and often posing significant health risks to the patient.

local spread: the process by which cancer cells grow and invade adjacent tissues, which can lead to further complications and the potential to metastasize if not controlled.

direct extension: the growth of cancerous cells into nearby tissues, often resulting in the destruction of healthy structures and making treatment more complex.

seeding: the dispersion of cancer cells from the primary tumor to distant sites within the body through bodily fluids, which can establish new tumor sites, complicating treatment efforts.

metastasis: the spread of cancer cells to distant parts of the body via the bloodstream or lymphatic system, leading to the formation of secondary tumors and significantly impacting patient prognosis.

tropism: the tendency of cancer cells to migrate to specific organs or tissues, often influenced by the molecular environment of those sites, which can affect the aggressiveness of the disease and treatment strategies.

teratoma: a type of tumor that contains a variety of tissue types, including hair, muscle, and bone, often arising from germ cells, and may be benign or malignant in nature.

carcinoma in situ: a localized abnormal cell growth that has not yet invaded surrounding tissues, often considered an early-stage cancer and usually has a favorable prognosis when detected early.

cachexia: a multifactorial syndrome characterized by severe body weight loss, muscle wasting, and anorexia, commonly seen in cancer patients, which can significantly impact their quality of life and response to treatment.

paraneoplastic syndrome: a group of symptoms that arise from substances produced by tumors, leading to various systemic effects, which can include hormonal imbalances and neurological symptoms, often complicating the management of the underlying cancer.

ectopic: a term used to describe the abnormal positioning or growth of tissues or organs, which can occur in various medical conditions, including tumors that develop in locations outside of their usual anatomical site.

palliative: a specialized approach to medical care that focuses on providing relief from the symptoms and stress of serious illness, aimed at improving quality of life for both the patient and their families.

occult: referring to a disease or condition that is hidden and not immediately apparent, often leading to delayed diagnosis and treatment, especially in cases of malignancies.

frank: a term used to describe something that is straightforward, clear, and honest, often applied in medical discussions to convey a candid assessment of a patient's condition or prognosis.

blast cell: a type of immature white blood cell that can proliferate abnormally in certain types of leukemia, indicating a disruption in normal hematopoiesis.